Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
Alarm
My account
Sign out
Sign-in required.
Sign in
About Us
Greetings
Our Vision
Our Platform
Our Partners
Pharmacometrics
What is M&S?
Methods
Benefits
Our Projects
Services
Early Phase Clinical Trials
Pharmacometric Analysis
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Matching Platform
Close
Site logo
About Us
Greetings
Our Vision
Our Platform
Our Partners
Pharmacometrics
What is M&S?
Methods
Benefits
Our Projects
Services
Early Phase Clinical Trials
Pharmacometric Analysis
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Matching Platform
MENU
Site logo
About Us
Pharmacometrics
Services
News
Contact Us
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Check out our press releases, events,
and learning sessions!
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
K
-BIO
R&
D
News
Updates and news
삼성에피스, ASH서 '솔리리스 시밀러' 3상 “포스터 발표” [2022.12.13]
0
0
14 Dec 2022
Views
220
Updates and news
JD바이오, ‘HTR2A 저해제’ NASH “호주 1상 승인” [2022.08.12]
0
0
17 Aug 2022
Views
348
Updates and news
이뮨앱스, 자가면역 ‘보체 C5 항체’ 1상 “美 IND 승인” [2022.08.02]
0
0
10 Aug 2022
Views
422
Updates and news
티움바이오, 中한소에 자궁내막증 신약 "1.7억弗 L/O" [2022.08.09]
0
0
10 Aug 2022
Views
363
Updates and news
아이디언스 표적항암 후보물질, 美 FDA 희귀의약품 지정 [2022.08.09]
0
0
10 Aug 2022
Views
401
Updates and news
샤페론, 코로나19 치료제 임상 2b·3상 계획 승인 [2022.01.13]
0
0
20 Jan 2022
Views
971
Updates and news
이수앱지스, ErbB3 타깃 항암신약 ‘ISU104’ 유럽 특허 [2021.07.02]
0
0
5 Jul 2021
Views
1109
Updates and news
대웅제약, 'PRS 저해제' IPF 호주1상 "안전성 확인" [2021.05.20]
0
0
21 May 2021
Views
1196
Updates and news
식약처, 유틸렉스 면역항암제 임상1·2상 계획 승인 [2021.05.17]
0
0
21 May 2021
Views
1115
Previous
1
2
3
4
5
Next
